device · product 1 of 1
Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic.
- Recall number
- Z-1947-2015
- Initiated
- June 12, 2015
- Classification
- Class II
- Status
- Terminated
- Recalling firm
- BioMerieux SA
- Quantity
- 674
App-derived interpretation
QC results were out of range resulting in false resistant strains.
Official device-enrichment evidence · Sourced
Process control
Inspect official wording and provenance
Reason for recall
QC results were out of range resulting in false resistant strains.
Code information
1002774320, 1002377890, 1002590470, 1002775330, 1002379610
Distribution pattern
Worldwide Distribution - USA (nationwide) to the states of AL, AR, CA, CO, FL, GA, IL, IN, KY, MD, MI, MN, MO, NE, NY, NC, OH, OK, OR, PA, TN, TX, UT, VA, WA, WV and WI., and to the countries of: Austria, Australia, Canada, Switzerland, Germany, Spain, France, United Kingdom, Greece, Hong Kong, India, Italy, Japan, Netherlands, Poland, Sweden, Thailand, Turkey, Saudi Arabia, Philippines, Slovenia, Kuwait, Brazil, Chile, Czech Republic, Algeria, South Africa, Kosovo, Costa Rica, Belarus, Guam, Honduras and Vietnam.